1. Home
  2. RYTM vs STRL Comparison

RYTM vs STRL Comparison

Compare RYTM & STRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • STRL
  • Stock Information
  • Founded
  • RYTM 2008
  • STRL 1955
  • Country
  • RYTM United States
  • STRL United States
  • Employees
  • RYTM N/A
  • STRL N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • STRL Military/Government/Technical
  • Sector
  • RYTM Health Care
  • STRL Industrials
  • Exchange
  • RYTM Nasdaq
  • STRL Nasdaq
  • Market Cap
  • RYTM 3.8B
  • STRL 3.8B
  • IPO Year
  • RYTM 2017
  • STRL N/A
  • Fundamental
  • Price
  • RYTM $61.33
  • STRL $188.01
  • Analyst Decision
  • RYTM Strong Buy
  • STRL Strong Buy
  • Analyst Count
  • RYTM 12
  • STRL 2
  • Target Price
  • RYTM $76.75
  • STRL $185.00
  • AVG Volume (30 Days)
  • RYTM 632.6K
  • STRL 518.6K
  • Earning Date
  • RYTM 05-07-2025
  • STRL 05-05-2025
  • Dividend Yield
  • RYTM N/A
  • STRL N/A
  • EPS Growth
  • RYTM N/A
  • STRL 78.58
  • EPS
  • RYTM N/A
  • STRL 8.56
  • Revenue
  • RYTM $136,863,000.00
  • STRL $2,106,345,000.00
  • Revenue This Year
  • RYTM $37.88
  • STRL $0.25
  • Revenue Next Year
  • RYTM $72.84
  • STRL $7.54
  • P/E Ratio
  • RYTM N/A
  • STRL $21.97
  • Revenue Growth
  • RYTM 48.88
  • STRL 4.84
  • 52 Week Low
  • RYTM $35.35
  • STRL $93.50
  • 52 Week High
  • RYTM $68.58
  • STRL $206.07
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 51.78
  • STRL 66.58
  • Support Level
  • RYTM $58.72
  • STRL $176.15
  • Resistance Level
  • RYTM $63.24
  • STRL $192.29
  • Average True Range (ATR)
  • RYTM 2.43
  • STRL 6.02
  • MACD
  • RYTM -0.15
  • STRL -1.43
  • Stochastic Oscillator
  • RYTM 65.51
  • STRL 73.48

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About STRL Sterling Infrastructure Inc.

Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions. .

Share on Social Networks: